Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-Release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder
This study has been completed.
Study NCT00309699   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: March 31, 2006   Last Updated: October 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Mood Disorders
Bipolar Disorder
Additional conditions recognized in this trial
Disease
More general conditions related to this trial
Affective Disorders, Psychotic
Mental Disorders
Pathologic Processes
Interventions listed in this trial
Placebo
Paliperidone ER
Quetiapine
Additional drug interventions recognized in this trial
9-hydroxy-risperidone
More general drug interventions related to this trial
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Johnson &Johnson Pharmaceutical Research &Development, L.L.C.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services